Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer

Colorectal cancer (CRC) is one of the most common malignances worldwide. Chemoresistance remains a major issue in the field of CRC treatment. The present study aimed to investigate the potential role of polo-like kinase 2 (Plk2) in chemoresistance in CRC. The associations between Plk2 and clinicopat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yuquan, Liu, Ying, Li, Qiubo, Chen, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873899/
https://www.ncbi.nlm.nih.gov/pubmed/29568868
http://dx.doi.org/10.3892/ijo.2018.4328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873899/
https://www.ncbi.nlm.nih.gov/pubmed/29568868
http://dx.doi.org/10.3892/ijo.2018.4328

Ejemplares similares